Eagle Pharmaceuticals Inc Cash Flow Reinvestment Rate
Eagle Pharmaceuticals Inc cash flow reinvestment rate. Eagle Pharmaceuticals Inc (EGRX) has a Cash Flow Reinvestment Rate of 0.00x as of December 2022, reinvesting $19.00K (capex $10.00K plus investments $-9.00K) from operating cash flow of $37.56 Million. Explore EGRX operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Eagle Pharmaceuticals Inc (2016–2022)
Cash flow reinvestment rate of Eagle Pharmaceuticals Inc from 2016 to 2022. Historical reinvestment intensity for Eagle Pharmaceuticals Inc across 7 annual periods. Explore Eagle Pharmaceuticals Inc (EGRX) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Eagle Pharmaceuticals Inc Cash Flow Reinvestment Rate by Year (2016–2022)
Eagle Pharmaceuticals Inc cash flow reinvestment rate by year from 2016 to 2022. Year-by-year capital reinvestment analysis for Eagle Pharmaceuticals Inc. For the full cash flow conversion analysis, see cash flow conversion of Eagle Pharmaceuticals Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 2.83x | $87.01 Million | $30.80 Million | $178.00K | ▲ +1312.1% |
| 2021 | 0.20x | $5.65 Million | $28.22 Million | $323.00K | ▼ -47.9% |
| 2020 | 0.38x | $18.99 Million | $49.50 Million | $747.00K | ▲ +1282.5% |
| 2019 | 0.03x | $1.55 Million | $55.99 Million | $777.00K | ▲ +446.6% |
| 2018 | 0.01x | $266.00K | $52.38 Million | $133.00K | ▼ -97.1% |
| 2017 | 0.18x | $10.37 Million | $58.92 Million | $5.19 Million | ▼ -85.9% |
| 2016 | 1.25x | $66.49 Million | $53.21 Million | $20.69 Million | — |